Prediction of risk for hepatocellular carcinoma by response of serum α-fetoprotein to entecavir therapy

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

(2014) Pauline Arends et al.   GUT

Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B

(2014) Jae-Jun Shim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Reappraisal of serum alpha-foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment

(2014) Gi-Ae Kim et al.   LIVER INTERNATIONAL

On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir

(2013) Grace L.H. Wong et al.   HEPATOLOGY

Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection – Results from a clinic-based longitudinal cohort

(2012) Hie-Won Hann et al.   EUROPEAN JOURNAL OF CANCER

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

(2012) Tetsuya Hosaka et al.   HEPATOLOGY

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

(2011) Roeland Zoutendijk et al.   HEPATOLOGY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine

(2011) Haruhiko Kobashi et al.   HEPATOLOGY RESEARCH

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY